Prolotherapy agent P2G is associated with upregulation of fibroblast growth factor-2 genetic expression in vitro

PURPOSE: Osteoarthritis (OA) is a prevalent, progressively degenerative disease. Researchers have rigorously documented clinical improvement in participants receiving prolotherapy for OA. The mechanism of action is unknown; therefore, basic science studies are required. One hypothesized mechanism is...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Exp Orthop
Главные авторы: Johnston, Elisha, Emani, Chandrakanth, Kochan, Andrew, Ghebrehawariat, Kidane, Tyburski, John, Johnston, Michael, Rabago, David
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2020
Предметы:
Original Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719583/
https://ncbi.nlm.nih.gov/pubmed/33280075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40634-020-00312-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы